[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368718-105":59,"doc-detail-368718-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","predictive-value-of-inflammatory-marker-plr-in-prostate-cancer","Predictive value of inflammatory marker PLR in prostate cancer","","This study investigates the correlation between inflammatory markers and prostate cancer and develops a predictive model with strong discriminative performance. The dataset is split into training (70%) and validation (30%) sets; logistic regression identifies risk factors, and ROC analysis assesses discrimination. Model accuracy is evaluated using a clinical decision curve and 10-fold cross-validation, while performance is compared across PSA ranges. A nomogram visualizes prediction, and associations with ISUP grading are analyzed.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/predictive-value-of-inflammatory-marker-plr-in-prostate-cancer/368718/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/predictive-value-of-inflammatory-marker-plr-in-prostate-cancer/368718.png","ImageObject",300,407,{"name":92,"@type":93},"Stanford","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the study?","Question",{"text":112,"@type":113},"To investigate the correlation between inflammatory markers and prostate cancer and to build a high-quality predictive model.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were risk factors and the predictive model evaluated?",{"text":117,"@type":113},"Logistic regression identified related risk factors in the training set, ROC curve analysis assessed discrimination, and accuracy was evaluated via clinical decision curve and 10-fold cross-validation.",{"name":119,"@type":110,"acceptedAnswer":120},"Which factors were identified as independent risk factors, and what did the model show?",{"text":121,"@type":113},"Age, prostate volume, total PSA, (f/t) PSA, and platelet-to-lymphocyte ratio (PLR) were independent risk factors. The model showed clinical advantage, stability, and elevated diagnostic efficacy in the PSA range of 4–20 ng/mL.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368718,1790532774,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Sun et al. BMC Urology (2025) 25:188 [https://doi.org/10.1186/s12894-025-01882-9](https://doi.org/10.1186/s12894-025-01882-9)  \nBMC Urology  \nRESEARCH Open Access  \nPredictive value of inflammatory marker PLRin prostate cancer  \nJunhao Sun 1†, Yu Song2†, Yunfei Tan3†, Limin Ma2* and Huyang Xie2*  \nAbstract  \nPurpose This study aims to investigate the correlation between inflammatory markers and prostate cancer with a good-quality predictive model.  \nMethods The original dataset was randomly split into a training set (70%) and a validation set (30%) . Logistic regression was used to examine the related risk factors within the training set. ROC curve analysis was conducted to evaluate the discriminative ability of risk factors for PCa. The accuracy and performance of the prediction model were evaluated using the clinical decision curve and 10-fold cross-validation. The diagnostic value of the model was compared across various PSA regions in the entire dataset. The nomogram was employed to illustrate the predictive model. Additionally, we analyzed the corresponding variables and the relationship between the International Society of Urological Pathology (ISUP) grading of PCa.  \nResults Age, prostate volume (PV), total PSA (tPSA),(f/t) PSA, and platelet-to-lymphocyte ratio were identified as independent risk factors for prostate cancer. The predictive model utilizing these parameters has shown significant clinical advantage, stability, and elevated diagnostic efficacy within the PSA range of 4–20 ng/mL. Additionally, significant differences in tPSA and PV were observed among PCa patients with varying ISUP grades.  \nConclusion PLR can serve as a predictive indicator for prostate cancer and, when integrated with additional clinical data, can enhance the detection rate of prostate cancer. Moreover, there was no correlation between PLR and the ISUP grade of PCa.  \nKeywords Predictive value, Platelet-to-lymphocyte ratio, Prostate cancer  \n†Junhao Sun, Yu Song andYunfei Tan contributed equally to this work.  \n*Correspondence: Limin Ma[ntmalimin@163.com](ntmalimin@163.com)[ ](ntmalimin@163.com)Huyang Xie [xiehuyang@ntu.edu.cn](xiehuyang@ntu.edu.cn)  \n1Department of Urology, Jiashan Hospital of Traditional Chinese Medicine, Jiaxing 314100, Zhejiang Province, China  \n2Department of Urology, Affiliated Hospital of Nantong University, No.20 West Temple Road, Nantong 226001, Jiangsu Province, China 3Department of Urology, Rudong County People’s Hospital,  \nNantong 226400, Jiangsu Province, China  \nIntroduction  \nProstate cancer (PCa) is a common cancer among older men, resulting in the death of nearly 300,000 men each year [1]. Prostate-specific antigen (PSA), the primary tool for routine prostate cancer screening, received its initial approval from the U.S. Food and Drug Administration (FDA) in the 1980s as a tumor marker for monitoring elderly prostate cancer patients [2]. However, the application of PSA as a biomarker has encountered numerous limitations to date. PSA is not a specific biomarker for prostate cancer, and some things can affect its levels, including age, acute prostatitis, ejaculation, catheterization, trauma, and particular medications [3].  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and yo","cbCaiijTlvvLvuMO","https://ap.wps.com/l/cbCaiijTlvvLvuMO","pdf",1942945,"English","# Abstract\n## Purpose\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Background and limitations of PSA\n## Need for cost-effective biomarkers\n## Inflammation and hematologic markers\n## Systemic immune inflammation index and PLR","[{\"question\":\"What is the main purpose of the study?\",\"answer\":\"To investigate the correlation between inflammatory markers and prostate cancer and to build a high-quality predictive model.\"},{\"question\":\"How were risk factors and the predictive model evaluated?\",\"answer\":\"Logistic regression identified related risk factors in the training set, ROC curve analysis assessed discrimination, and accuracy was evaluated via clinical decision curve and 10-fold cross-validation.\"},{\"question\":\"Which factors were identified as independent risk factors, and what did the model show?\",\"answer\":\"Age, prostate volume, total PSA, (f/t) PSA, and platelet-to-lymphocyte ratio (PLR) were independent risk factors. The model showed clinical advantage, stability, and elevated diagnostic efficacy in the PSA range of 4–20 ng/mL.\"}]","Predictive value of inflammatory marker PLR in prostate cancer | PDF",1790178173,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/854a04a96eb8b4c33270aca0eac13633.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e154ae1b47084cd19e1b75f28cdca7d9.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd52dd72c5ad726114aae4cc8b5eeee8.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d15b5e78fc5eecee5467e9aadf1a0800.webp",980,1306]